Literature DB >> 168083

The sources of plasma cyclic AMP: studies in the rat using isoprenaline, nicotinic acid and glucagon.

R C Strange, O D Mjos.   

Abstract

The effects of intravenous administration of isoprenaline, glucagon and nicotinic acid on plasma concentrations of cyclic AMP in rats are described. In order to determine the relative importance of the liver as a source of extracellular cyclic AMP, the effects of the hormones were investigated in intact and functionally hepatectomised rats. The results showed that hepatectomy did not prevent an isoprenaline-stimulated increase in plasma cyclic AMP concentrations, although glucagon was without effect on plasma nucleotide concentrations in this group of animals. It is suggested that the liver is essential for the action of glucagon but that isoprenaline can increase plasma cyclic AMP concentrations in hepatectomised animals by increasing extrahepatic release of the nucleotide. Since inhibition of adipose tissue lipolysis with nicotinic acid did not prevent an isoprenaline or glucagon-stimulated increase in plasma cyclic AMP concentrations, adipose tissue is discounted as a major source of plasma cyclic AMP.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168083     DOI: 10.1111/j.1365-2362.1975.tb00440.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  15 in total

1.  Plasma cyclic AMP levels during a secretin-caerulein pancreatic function test in liver and pancreatic disease.

Authors:  M Adler; P Robberecht; M G Poitevin; J Christophe
Journal:  Gut       Date:  1978-03       Impact factor: 23.059

2.  Plasma dopamine-beta-hydroxylase in childhood psychosis.

Authors:  R H Belmaker; J Hattab; R P Ebstein
Journal:  J Autism Child Schizophr       Date:  1978-09

3.  Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis.

Authors:  A Francavilla; A F Jones; T E Starzl
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

4.  Plasma cyclic adenosine-3', 5'-monophosphate response to glucagon in patients with liver disease.

Authors:  T F Davies; K Prudhoe; A P Douglas
Journal:  Br Med J       Date:  1976-04-17

5.  The release of adenosine 3':5'-cyclic monophosphate from the isolated perfused rat heart.

Authors:  J A O'Brien; R C Strange
Journal:  Biochem J       Date:  1975-11       Impact factor: 3.857

6.  Anomalous plasma cyclic AMP responses to glucagon in patients with liver disease.

Authors:  H Maekubo; T Matsushima; F Okada; M Honma; M Ui
Journal:  Dig Dis Sci       Date:  1980-09       Impact factor: 3.199

7.  The effect of selective and non-selective beta-adrenoceptor blockade, and of naloxone infusion, on the hormonal mechanisms of recovery from insulin-induced hypoglycaemia in man.

Authors:  J G Armitstead; S L Lightman; M J Brown; R C Causon; N J Vaughan
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

8.  Increased plasma cyclic nucleotide concentrations in congestive heart failure.

Authors:  K Ogawa; H Shiozu; K Mizuno; M Ban; T Ito; T Satake
Journal:  Br Heart J       Date:  1984-11

9.  The effect of haloperidol on epinephrine-stimulated adenylate cyclase in humans.

Authors:  R H Belmaker; R P Ebstein; H Schoenfeld; R Rimon
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

10.  Subsensitivity of human beta-adrenergic adenylate cyclase after salbutamol treatment of depression.

Authors:  B Lerer; R P Ebstein; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.